Long-term benefit of redo sympathetic renal denervation in a patient with resistant hypertension

Sympathetic renal denervation (RDN) has been demonstrated as a potential treatment option for patients with resistant hypertension [1]. Despite discouraging results after the SYMPLICITY HTN-3 trial several techniques and catheters were introduced to the market and data confirming adequate and effect...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Tomasz Tokarek, Renata Rajtar-Salwa, Łukasz Rzeszutko, Stanisław Bartuś
Formato:	article
Lenguaje:	EN
Publicado:	Termedia Publishing House 2021
Materias:	Medicine R
Acceso en línea:	https://doaj.org/article/67cdd25076de4cc0bf06f9a57988575e
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:67cdd25076de4cc0bf06f9a57988575e
record_format	dspace
spelling	oai:doaj.org-article:67cdd25076de4cc0bf06f9a57988575e2021-12-02T19:19:13ZLong-term benefit of redo sympathetic renal denervation in a patient with resistant hypertension1734-93381897-429510.5114/aic.2021.107513https://doaj.org/article/67cdd25076de4cc0bf06f9a57988575e2021-07-01T00:00:00Zhttps://www.termedia.pl/Long-term-benefit-of-redo-sympathetic-renal-denervation-in-a-patient-with-resistant-hypertension,35,44605,1,1.htmlhttps://doaj.org/toc/1734-9338https://doaj.org/toc/1897-4295Sympathetic renal denervation (RDN) has been demonstrated as a potential treatment option for patients with resistant hypertension [1]. Despite discouraging results after the SYMPLICITY HTN-3 trial several techniques and catheters were introduced to the market and data confirming adequate and effective denervation are growing [1, 2]. In current guidelines invasive methods are not recommended as routine treatment of resistant hypertension [3, 4]. However, a highly selected group of patients not responding to aggressive medical treatment might benefit from this method [1–4].Tomasz TokarekRenata Rajtar-SalwaŁukasz RzeszutkoStanisław BartuśTermedia Publishing HousearticleMedicineRENAdvances in Interventional Cardiology, Vol 17, Iss 2, Pp 239-241 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R
spellingShingle	Medicine R Tomasz Tokarek Renata Rajtar-Salwa Łukasz Rzeszutko Stanisław Bartuś Long-term benefit of redo sympathetic renal denervation in a patient with resistant hypertension
description	Sympathetic renal denervation (RDN) has been demonstrated as a potential treatment option for patients with resistant hypertension [1]. Despite discouraging results after the SYMPLICITY HTN-3 trial several techniques and catheters were introduced to the market and data confirming adequate and effective denervation are growing [1, 2]. In current guidelines invasive methods are not recommended as routine treatment of resistant hypertension [3, 4]. However, a highly selected group of patients not responding to aggressive medical treatment might benefit from this method [1–4].
format	article
author	Tomasz Tokarek Renata Rajtar-Salwa Łukasz Rzeszutko Stanisław Bartuś
author_facet	Tomasz Tokarek Renata Rajtar-Salwa Łukasz Rzeszutko Stanisław Bartuś
author_sort	Tomasz Tokarek
title	Long-term benefit of redo sympathetic renal denervation in a patient with resistant hypertension
title_short	Long-term benefit of redo sympathetic renal denervation in a patient with resistant hypertension
title_full	Long-term benefit of redo sympathetic renal denervation in a patient with resistant hypertension
title_fullStr	Long-term benefit of redo sympathetic renal denervation in a patient with resistant hypertension
title_full_unstemmed	Long-term benefit of redo sympathetic renal denervation in a patient with resistant hypertension
title_sort	long-term benefit of redo sympathetic renal denervation in a patient with resistant hypertension
publisher	Termedia Publishing House
publishDate	2021
url	https://doaj.org/article/67cdd25076de4cc0bf06f9a57988575e
work_keys_str_mv	AT tomasztokarek longtermbenefitofredosympatheticrenaldenervationinapatientwithresistanthypertension AT renatarajtarsalwa longtermbenefitofredosympatheticrenaldenervationinapatientwithresistanthypertension AT łukaszrzeszutko longtermbenefitofredosympatheticrenaldenervationinapatientwithresistanthypertension AT stanisławbartus longtermbenefitofredosympatheticrenaldenervationinapatientwithresistanthypertension
_version_	1718376856109973504

Long-term benefit of redo sympathetic renal denervation in a patient with resistant hypertension

Ejemplares similares